News
Design your days with intention — like a summer camp schedule for grown-ups — and turn the ordinary into something ...
Recent technological advancements have made recovery from paralysis a real possibility for the first time in history.
The acquisition of Serva Electrophoresis by LICORbio is effective immediately, with integration activities already underway.
The Hopewell site is equipped to support clinical-stage development, process-development, and scaleup for cell and gene therapy programs.
Vetter has invested approximately $285 million in the new Des Plaines clinical manufacturing site, which is expected to open ...
The new facility will combine academic innovation with industrial applications, catalyzing economic growth and training bioengineers.
A recent research finding adds to evidence that brain inflammation is a major driver of neurodegenerative disorders such as ...
Velsera’s technology enables compliant access to sensitive datasets while keeping data within the control of its source ...
Labviva connects pharmaceutical R&D labs directly to 90% of all raw materials suppliers available in the United States and Europe.
LOTTE will manufacture antibody drug substance for Ottimo Pharma’s product at LOTTE’s Syracuse Bio Campus in New York.
AAVs play a key role in delivering gene therapies, and precise measurement of the empty/full capsid ratio—a critical quality ...
Bionova will also use Cytiva’s Fast Trak process development services to help advance their entry into genomic medicines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results